logo-loader
NASDAQ:INFI

Infinity Pharmaceuticals Inc.

Receive alerts
Market:
NASDAQ
Market Cap:
$50.83 m
Price
0.89 USD
Change
6.86%
52 weeks high
1.67
52 weeks low
0.60

In brief

Infinity Pharmaceuticals, Inc. (IPI) is a drug discovery and development company. The Company’s lead product candidate, IPI-504 (retaspimycin hydrochloride), is an intravenously administered small molecule inhibitor of heat shock protein 90 (Hsp90).